Cellics Therapeutics
San Diego, US · Founded 2014 · Delaware corporation
Cellics Therapeutics is a therapeutics company; its website is a placeholder page providing only contact and location details, with no description of its products or focus.
Founders & leadership
HZ
Huiqing ZhuExecutive
LX
Lili XieinCo-Founder & Board Director
Board
DJ
Dai JinmingBoard director
Reported raises · per SEC filings
Form D private placements$33M disclosed across 4 rounds · 2016–2022
▶$7MraisedFeb 2022 · 1 investors · BiotechnologyRule 506(b)
▶$7MraisedFeb 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cihui LiDirector
- Angela Fang ChenDirector
- Liangfang ZhangDirector
- Lili XieExecutive Officer
- Wei ShenDirector
- Jie ZhangExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $7M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedJun 2020 · 3 investors · BiotechnologyRule 506(b)
▶$13MraisedJun 2020 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Huiqing ZhuExecutive Officer
- Lili XieExecutive Officer, Director
- Angela Fang ChenDirector
- Dai JinmingDirector
- Weiwei GaoDirector
- Offering amount
- $13M
- Amount sold
- $13M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedApr 2018 · 4 investors · BiotechnologyRule 506(b)
▶$7MraisedApr 2018 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dai JinmingDirector
- Huiqing ZhuExecutive Officer, Director
- Lili XieExecutive Officer, Director
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$6MraisedApr 2017 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Huiqing ZhuExecutive Officer, Director
- Dai JimmingDirector
- Lili XieExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlapKite Pharma12 shared keywordsKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.
Linkcelltx9 shared keywordsLink Cell Therapies is a biotechnology company developing logic-gate LINK CAR-T cell therapies aimed at treating solid and liquid tumors. It works in the cancer immunotherapy space and has a strategic collaboration with Johnson & Johnson.
Cellectis8 shared keywordsCellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.
Celldex Therapeutics, Inc.7 shared keywordsCelldex is a biotechnology company developing therapeutics across therapeutic areas including immunology and inflammation. The page shown is a board director biography rather than a company overview.
Lyell7 shared keywordsLyell develops CAR T-cell therapies for cancer patients by leveraging deep expertise in T-cell biology and oncology. The company operates an integrated pipeline spanning discovery through manufacturing and clinical trials, with its own manufacturing facility in Washington.
Solu6 shared keywordsSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Companies competing with Cellics Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Cellics Therapeutics do?
- Cellics Therapeutics is a therapeutics company; its website is a placeholder page providing only contact and location details, with no description of its products or focus.
- How much funding has Cellics Therapeutics raised?
- Cellics Therapeutics has disclosed $33M raised across 4 rounds.
- Where is Cellics Therapeutics headquartered?
- Cellics Therapeutics is headquartered in San Diego, US.